Latest Security News

Renascor Resources has completed key preparatory milestones for its Purified Spherical Graphite demonstration plant in Adelaide, with construction set to begin next month. The facility aims to challenge China’s dominance in battery anode materials using an innovative, eco-friendly purification process.

Noxopharm has successfully completed the third dosing phase of its HERACLES trial for SOF-SKN™, confirming safety and moving forward to the highest dose cohort in this pioneering autoimmune drug study.

An independent in vivo study from the University of South Florida reveals ArtemiC™ significantly boosts survival and reduces inflammation in a severe viral model, reinforcing its promise as a novel immunomodulatory therapy.

Alligator Energy has secured final regulatory approval to begin its in-situ Field Recovery Trial at the Samphire Uranium Project, advancing the development of its recently upgraded Blackbush Deposit resource.

Regal Partners reports a 48% drop in statutory profit for H1 2025 despite growing funds under management to $17.7 billion, while strategically expanding into hotel real estate with the Mayfair Hotel acquisition.

Tasmea Limited has reported a robust FY25 with a record $600 million order book for FY26, underpinning a confident earnings outlook. The company’s strategic acquisitions and strong organic growth fuel a 32% NPAT increase forecast for FY26.

Diatreme Resources has achieved a significant regulatory milestone with Project Status granted across its silica sand tenements in Far North Queensland, alongside critical tenure renewals that preserve its strategic landholdings. This development strengthens its pathway toward long-term production of low-iron, high-purity silica sand.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

GDI Property Group reports robust leasing activity with over 32,000sqm leased in FY25, fueling a 20% increase in Funds From Operations. Strategic asset sales and refinancing position the company well for continued growth in a tightening Perth office market.

GDI has reported a strong FY25 with a 22% increase in Property Funds From Operations, robust leasing activity, and significant asset sales, while maintaining its distribution guidance for FY26.

GDI Property Group has reported a strong turnaround in FY25, posting a $35.6 million net profit and a 20% increase in Funds From Operations, while maintaining its distribution at 5 cents per security.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.